Drug Profile
Research programme: oxocalanolide - Sarawak Medichem Pharmaceuticals
Alternative Names: oxocalanolide; SMP-610Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Sarawak MediChem Pharmaceuticals
- Class Coumarins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cytomegalovirus infections; HIV infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cytomegalovirus infections in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-infections in USA
- 26 Jun 2006 This programme is still in active development